These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 1168251

  • 21. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K, Sato T, Shimoda M, Nakagawasai O, Niijima F, Kawamura S, Furuta S, Sato T, Satoh S, Silberring J, Terenius L, Tadano T.
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains.
    Brase DA, Loh HH, Way EL.
    J Pharmacol Exp Ther; 1977 May; 201(2):368-74. PubMed ID: 558328
    [Abstract] [Full Text] [Related]

  • 23. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL, Welch SP.
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [Abstract] [Full Text] [Related]

  • 24. [Assessment of morphine-type physical dependence liability in mice using the drug-admixed food method].
    Suzuki T, Yoshii T, Yanaura S.
    Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):19-24. PubMed ID: 6541614
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 34. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
    Su RB, Lu XQ, Huang Y, Liu Y, Gong ZH, Wei XL, Wu N, Li J.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):155-62. PubMed ID: 18455724
    [Abstract] [Full Text] [Related]

  • 35. Establishment of physical dependence mice by oral ingestion of morphine.
    McMillan DE, Waddell FB, Cathcart CF.
    J Pharmacol Exp Ther; 1974 Sep 10; 190(3):416-9. PubMed ID: 4472104
    [No Abstract] [Full Text] [Related]

  • 36. [Comparative study of the physical dependence on proline analog of dermorphin and morphine].
    Guzevatykh LS, Valuĭskikh DV, Voronina TA, Emel'ianova TG, Andreeva LA, Alfeeva LIu, Miasoedov NF.
    Eksp Klin Farmakol; 2005 Sep 10; 68(3):16-9. PubMed ID: 16047673
    [Abstract] [Full Text] [Related]

  • 37. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C, Araki H, Nagata M, Shimosaka R, Shibata K, Suemaru K, Kawasaki H, Gomita Y.
    Behav Brain Res; 2005 Jun 03; 161(1):107-12. PubMed ID: 15904717
    [Abstract] [Full Text] [Related]

  • 38. Assessment of acute and chronic morphine dependence in male and female mice.
    Kest B, Palmese CA, Hopkins E, Adler M, Juni A.
    Pharmacol Biochem Behav; 2001 Sep 03; 70(1):149-56. PubMed ID: 11566152
    [Abstract] [Full Text] [Related]

  • 39. [The potential antinarcotic effects of guanfacine].
    Marusov IV, Bogdanov EG, Marusova IB.
    Eksp Klin Farmakol; 1996 Sep 03; 59(3):24-7. PubMed ID: 8974578
    [Abstract] [Full Text] [Related]

  • 40. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV, Andreev BV.
    Eksp Klin Farmakol; 2000 Sep 03; 63(1):19-23. PubMed ID: 10763104
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.